GoodRx Holdings Inc. (NASDAQ:GDRX) went up by 2.02% from its latest closing price compared to the recent 1-year high of $64.22. The company’s stock price has collected -1.44% of loss in the last five trading sessions. Press Release reported on 07/15/21 that GoodRx Announces Date for Second Quarter 2021 Earnings Release and Conference Call
Is It Worth Investing in GoodRx Holdings Inc. (NASDAQ :GDRX) Right Now?
Opinions of the stock are interesting as 7 analysts out of 15 who provided ratings for GoodRx Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 7 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $42.15, which is $12.4 above the current price. GDRX currently public float of 63.17M and currently shorts hold a 25.98% ratio of that float. Today, the average trading volume of GDRX was 1.92M shares.
GDRX’s Market Performance
GDRX stocks went down by -1.44% for the week, with a monthly drop of -18.07% and a quarterly performance of -20.21%. The volatility ratio for the week stands at 5.02% while the volatility levels for the past 30 days are set at 4.67% for GoodRx Holdings Inc.. The simple moving average for the period of the last 20 days is -9.70% for GDRX stocks with a simple moving average of -26.52% for the last 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Robert W. Baird repeating the rating for GDRX by listing it as a “Neutral.” The predicted price for GDRX in the upcoming period, according to Robert W. Baird is $37 based on the research report published on May 28th of the current year 2021.
Evercore ISI, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $50. The rating they have provided for GDRX stocks is “Outperform” according to the report published on April 06th, 2021.
Guggenheim gave a rating of “Buy” to GDRX, setting the target price at $52 in the report published on January 25th of the current year.
GDRX Trading at -10.88% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.99% of loss for the given period.
Volatility was left at 4.67%, however, over the last 30 days, the volatility rate increased by 5.02%, as shares sank -19.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.26% lower at present.
During the last 5 trading sessions, GDRX fell by -1.44%, which changed the moving average for the period of 200-days by -38.40% in comparison to the 20-day moving average, which settled at $33.78. In addition, GoodRx Holdings Inc. saw -23.57% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at GDRX starting from Azad Babak, who sale 12,500 shares at the price of $32.98 back on Jul 09. After this action, Azad Babak now owns 0 shares of GoodRx Holdings Inc., valued at $412,258 using the latest closing price.
Idea Men, LLC, the 10% Owner of GoodRx Holdings Inc., sale 70,201 shares at $33.02 during a trade that took place back on Jul 08, which means that Idea Men, LLC is holding 0 shares at $2,318,150 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- -48.55 for the present operating margin
- +91.28 for the gross margin
The net margin for GoodRx Holdings Inc. stands at -53.32. The total capital return value is set at -30.10, while invested capital returns managed to touch -33.46. Equity return is now at value -107.30, with -25.40 for asset returns.
Based on GoodRx Holdings Inc. (GDRX), the company’s capital structure generated 99.10 points at debt to equity in total, while total debt to capital is 49.77. Total debt to assets is 47.16, with long-term debt to equity ratio resting at 97.47. Finally, the long-term debt to capital ratio is 48.96.
When we switch over and look at the enterprise to sales, we see a ratio of 28.21, with the company’s debt to enterprise value settled at 0.05. The receivables turnover for the company is 7.57 and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 18.24.